Erin Allman‑Updyke and Erin Welsh
speaker
988 appearances
1 recordings
1 series
first heard Aug 2026
last heard 4 Aug
Erin Allman‑Updyke and Erin Welsh’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Aug 2026 with 1.
Appearances
Yeah.
It's incredible.
So thank you.
Thank you.
Okay, Erin, tell me about this guy and how he came up with statins and everything else, okay?
Absolutely.
Let's take a quick break and we'll do all of that.
Last week, I took us through the story of cholesterol and how it earned its reputation as a major cause of cardiovascular disease.
Over the course of about seven decades, from the 1910s to the early 1980s, researchers put the pieces of the cholesterol puzzle together using a wide range of studies.
We had experimental ones like Anichkow's atherosclerotic rabbits.
There were analytical ones, epidemiological ones like the Framingham Heart Study, genetic ones, and mechanistic ones like Brown and Goldstein's Nobel Prize-winning work characterizing the LDL receptor.
Lots of different studies.
Lots of different lines of evidence.
Yes, yes.
And this week, I'm going to pick up with the final piece of this puzzle, cholesterol-lowering drugs and some of the controversy that surrounds them.
By the 1970s, much of the cardiology world, like researchers, physicians, and institutes, they saw the link between cholesterol and cardiovascular disease as a done deal.
This is established.
Okay, now let's proceed from here.
But that knowledge didn't reach beyond that realm of experts.
And many physicians remained either skeptical or oblivious to this new knowledge.
Showing 81–100 of 988 · page 5 of 50
← Previous
Next →